Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning

Area of Science:

• Stem Cell Biology
• Biotechnology
• Artificial Intelligence

Background:

• Induced pluripotent stem cell (iPSC) technology offers potential for therapeutic cell and organ generation.
• Clinical application of iPSCs is hindered by challenges in quality, safety, and standardization.
• Current methods for iPSC characterization are time-consuming and labor-intensive.

Purpose of the Study:

• To review recent advancements in artificial intelligence (AI) applications for iPSC evaluation.
• To highlight AI's role in overcoming bottlenecks in iPSC manufacturing and clinical translation.
• To explore AI-driven solutions for assessing cell identity and function during iPSC differentiation.

Main Methods:

• Review of experimental studies utilizing AI for iPSC analysis.
• Focus on AI-based approaches for quality control and validation of iPSCs and their derivatives.
• Examination of AI's utility in streamlining iPSC reprogramming and differentiation processes.

Main Results:

• AI methods show promise in accelerating and improving the accuracy of iPSC characterization.
• AI can help standardize protocols for cell reprogramming and functional differentiation.
• AI-based tools may revolutionize the management and application of iPSCs in regenerative medicine.

Conclusions:

• AI presents a powerful toolkit for enhancing the quality and safety assessment of iPSCs.
• AI-driven approaches are crucial for overcoming current limitations in iPSC-based therapies.
• The integration of AI is poised to accelerate the clinical translation of iPSC technology.